Literature DB >> 15519742

Ethanol increases nuclear factor-kappa B activity in human astroglial cells.

Randall L Davis1, Peter J Syapin.   

Abstract

Alcohol abuse adversely affects essentially all the organs of the body, either directly or indirectly. Ethanol may contribute to brain damage via inflammation. Ethanol may also alter CNS immunocompetence and further the progression of certain CNS infections. Nuclear factor (NF)-kappa B helps regulate inflammatory gene expression in glia. It is possible that ethanol effects on CNS pathology are partly a consequence of ethanol modulation of NF-kappa B-associated pathways in glia. We have assessed the effects of 0.5-6 h ethanol exposure on cytokine (5 ng/ml interleukin-1 beta + 100 ng/ml interferon gamma + 30 ng/ml tumor necrosis factor-alpha)-induced NF-kappa B activation in human A172 astroglial cells. Immunoblot analysis indicated that NF-kappa B p65 nuclear translocation occurred within 0.5 h after cytokine stimulation. Stimulation in the presence of ethanol resulted in increased nuclear p65 levels at 3 h, with 200 mM causing a greater increase than 50 mM ethanol. Gel shift assay data suggested that cytokine-induced NF-kappa B binding activity was greatest in cells exposed to 50 mM ethanol, followed by 200 and 0 mM ethanol exposed cells, respectively. Thus, in cytokine-stimulated cells, 200 mM ethanol resulted in greater nuclear p65 levels, yet, 50 mM ethanol exposure resulted in more pronounced DNA binding by NF-kappa B. These findings demonstrate that acute ethanol enhances p65 activity in human astroglia and further support the hypothesis that ethanol-mediated brain pathology involves modulation of NF-kappa B pathways. A better understanding of the mechanistic events involved in ethanol-induced CNS pathology should provide for therapeutic strategies to combat detrimental effects of alcohol on the CNS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15519742     DOI: 10.1016/j.neulet.2004.08.051

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  23 in total

Review 1.  The role of neuroimmune signaling in alcoholism.

Authors:  Fulton T Crews; Colleen J Lawrimore; T Jordan Walter; Leon G Coleman
Journal:  Neuropharmacology       Date:  2017-02-01       Impact factor: 5.250

2.  The opioid antagonist, β-funaltrexamine, inhibits NF-κB signaling and chemokine expression in human astrocytes and in mice.

Authors:  Randall L Davis; Subhas Das; J Thomas Curtis; Craig W Stevens
Journal:  Eur J Pharmacol       Date:  2015-05-22       Impact factor: 4.432

3.  Increased expression of M1 and M2 phenotypic markers in isolated microglia after four-day binge alcohol exposure in male rats.

Authors:  Hui Peng; Chelsea R Geil Nickell; Kevin Y Chen; Justin A McClain; Kimberly Nixon
Journal:  Alcohol       Date:  2017-06-20       Impact factor: 2.405

4.  Innate Immune Signaling and Alcohol Use Disorders.

Authors:  Leon G Coleman; Fulton T Crews
Journal:  Handb Exp Pharmacol       Date:  2018

5.  Protection against alcohol-induced neuronal and cognitive damage by the PPARγ receptor agonist pioglitazone.

Authors:  Andrea Cippitelli; Esi Domi; Massimo Ubaldi; James C Douglas; Hong Wu Li; Gregory Demopulos; George Gaitanaris; Marisa Roberto; Paul D Drew; Cynthia J M Kane; Roberto Ciccocioppo
Journal:  Brain Behav Immun       Date:  2017-02-03       Impact factor: 7.217

6.  The opioid antagonist, beta-funaltrexamine, inhibits chemokine expression in human astroglial cells.

Authors:  Randall L Davis; Daniel J Buck; Neda Saffarian; Craig W Stevens
Journal:  J Neuroimmunol       Date:  2007-05-01       Impact factor: 3.478

7.  Β-funaltrexamine inhibits chemokine (CXCL10) expression in normal human astrocytes.

Authors:  Randall L Davis; Subhas Das; Daniel J Buck; Craig W Stevens
Journal:  Neurochem Int       Date:  2013-01-31       Impact factor: 3.921

Review 8.  Fetal alcohol spectrum disorders and neuroimmune changes.

Authors:  Paul D Drew; Cynthia J M Kane
Journal:  Int Rev Neurobiol       Date:  2014       Impact factor: 3.230

9.  Up-regulation of steroid biosynthesis by retinoid signaling: Implications for aging.

Authors:  Pulak R Manna; Cloyce L Stetson; Carol Daugherty; Ikue Shimizu; Peter J Syapin; Ghislaine Garrel; Joelle Cohen-Tannoudji; Ilpo Huhtaniemi; Andrzej T Slominski; Kevin Pruitt; Douglas M Stocco
Journal:  Mech Ageing Dev       Date:  2015-08-21       Impact factor: 5.432

Review 10.  Mechanisms of neurodegeneration and regeneration in alcoholism.

Authors:  Fulton T Crews; Kim Nixon
Journal:  Alcohol Alcohol       Date:  2008-10-21       Impact factor: 2.826

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.